Scientists try to reprogram Patient's own cells to fix bleeding disorder

This is an early safety study testing a new gene therapy approach for adults with severe hemophilia A, a serious bleeding disorder. Researchers will collect a patient's own blood stem cells, genetically modify them in a lab to produce the missing clotting factor inside platelets, and then return the cells to the patient. The main goal is to see if this process is safe and feasible, and if the modified cells can create platelets that help control bleeding.